Fredeswinda Romero-Bueno

Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease

Fredeswinda Romero-Bueno, P. Díaz del Campo, Ernesto Trallero‐Araguás et al. · Seminars in Arthritis and Rheumatism · 2020 · 175 citations · Full text

Autoimmune Disease, Melanoma, Immunology +7

Anti-TNF-  therapy in patients with refractory uveitis due to Behcet's disease: a 1-year follow-up study of 124 patients

V. Calvo-Río, Ricardo Blanco, E. Beltrán et al. · Lara D. Veeken · 2014 · 121 citations · Full text

Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases

Belén Atienza‐Mateo, J. L. Martín-Varillas, V. Calvo-Río et al. · Arthritis & Rheumatology · 2019 · 105 citations · Full text

Efficacy of rituximab in slowing down progression of rheumatoid arthritis–related interstitial lung disease: data from the NEREA Registry

Cristina Vadillo, Maria Asunción Nieto, Fredeswinda Romero-Bueno et al. · Lara D. Veeken · 2019 · 87 citations · Full text

Why choose cyclosporin A as first-line therapy in COVID-19 pneumonia

Olga Sánchez‐Pernaute, Fredeswinda Romero-Bueno, Albert Selva-O’Callaghan · Reumatología Clínica · 2020 · 40 citations · Full text

Antiviral Therapy, Cyclosporin A, Infectious Respiratory Disease +4